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Summary
Background Internet-based interventions for smoking cessation could help millions of people stop smoking at very 
low unit costs; however, long-term biochemically veriﬁ ed evidence is scarce and such interventions might be less 
eﬀ ective for smokers with low socioeconomic status than for those with high status because of lower online literacy to 
engage with websites. We aimed to assess a new interactive internet-based intervention (StopAdvisor) for smoking 
cessation that was designed with particular attention directed to people with low socioeconomic status.
Methods We did this online randomised controlled trial between Dec 6, 2011, and Oct 11, 2013, in the UK. Participants 
aged 18 years and older who smoked every day were randomly assigned (1:1) to receive treatment with StopAdvisor or 
an information-only website. Randomisation was automated with an unseen random number function embedded in 
the website to establish which treatment was revealed after the online baseline assessment. Recruitment continued 
until the required sample size had been achieved from both high and low socioeconomic status subpopulations. 
Participants, and researchers who obtained data and did laboratory analyses, were masked to treatment allocation. 
The primary outcome was 6 month sustained, biochemically veriﬁ ed abstinence. The main secondary outcome was 
6 month, 7 day biochemically veriﬁ ed point prevalence. Analysis was by intention to treat. Homogeneity of intervention 
eﬀ ect across the socioeconomic subsamples was ﬁ rst assessed to establish whether overall or separate subsample 
analyses were appropriate. The study is registered as an International Standard Randomised Controlled Trial, number 
ISRCTN99820519.
Findings We randomly assigned 4613 participants to the StopAdvisor group (n=2321) or the control group (n=2292); 
2142 participants were of low socioeconomic status and 2471 participants were of high status. The overall rate of 
smoking cessation was similar between participants in the StopAdvisor and control groups for the primary (237 [10%] 
vs 220 [10%] participants; relative risk [RR] 1·06, 95% CI 0·89–1·27; p=0·49) and the secondary (358 [15%] vs 332 
[15%] participants; 1·06, 0·93–1·22; p=0·37) outcomes; however, the intervention eﬀ ect diﬀ ered across socioeconomic 
status subsamples (1·44, 0·99–2·09; p=0·0562 and 1·37, 1·02–1·84; p=0·0360, respectively). StopAdvisor helped 
participants with low socioeconomic status stop smoking compared with the information-only website (primary 
outcome: 90 [8%] of 1088 vs 64 [6%] of 1054 participants; RR 1·36, 95% CI 1·00–1·86; p=0·0499; secondary outcome: 
136 [13%] vs 100 [10%] participants; 1·32, 1·03–1·68, p=0·0267), but did not improve cessation rates in those with 
high socioeconomic status (147 [12%] of 1233 vs 156 [13%] of 1238 participants; 0·95, 0·77–1·17; p=0·61 and 222 [18%] 
vs 232 [19%] participants; 0·96, 0·81–1·13, p=0·64, respectively).
Interpretation StopAdvisor was more eﬀ ective than an information-only website in smokers of low, but not high, 
socioeconomic status. StopAdvisor could be implemented easily and made freely available, which would probably 
improve the success rates of smokers with low socioeconomic status who are seeking online support.
Funding National Prevention Research Initiative.
Copyright © Brown et al. Open Access article distributed under the terms of CC BY. 
Introduction
Tobacco smoking is estimated to cause more than 
6 million deaths worldwide every year,1 and is a major 
contributor to health inequalities.2 Almost all the 
mortality and morbidity associated with smoking could 
be avoided by smokers quitting before age 30 years;3 
however, in most developed countries, less than a quarter 
of smokers quit before this age, despite most wanting 
and trying to stop.4 Face-to-face support combined with 
drugs is the most eﬀ ective intervention for cessation, 
whereas unaided quitting is one of the least eﬀ ective 
methods.5,6 Despite this ﬁ nding, even in the UK, where 
treatment is widely accessible at little or no cost, most 
smokers do not use face-to-face support and almost half 
attempt to stop unaided.7 Improved ways to help and 
engage smokers who are trying to stop are urgently 
needed, particularly for those from low socioeconomic 
status groups who want to stop as much as other 
smokers, but ﬁ nd it more diﬃ  cult,8 further widening 
social inequalities.
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Internet support is a low-cost option for treatment of 
smoking cessation, which could reach millions of 
smokers who would otherwise attempt to quit unaided. 
Roughly 70% of smokers in the UK have regular internet 
access and almost half are interested in use of online 
support during a future quit attempt.9 The internet could 
appeal to smokers who are reluctant to engage with face-
to-face support by oﬀ ering increased convenience, 
conﬁ dentiality, and reduced stigma, while presenting an 
alternative for those struggling to access face-to-face 
support because of mobility or geographical barriers. The 
beneﬁ ts compared with other low-cost and convenient 
alternatives, such as written materials, include 
opportunities for interactivity and tailoring. Despite the 
potential of internet-based interventions, previous 
research into their eﬀ ectiveness has produced mixed 
results and is limited by a scarcity of biochemically 
veriﬁ ed long-term outcomes.10 Which components 
account for the diﬀ erences in eﬀ ectiveness between 
diﬀ erent assessments is unclear, because internet 
interventions have often been presented as so-called 
black boxes, with restricted description of their content.10 
To establish the crucial components of an eﬀ ective 
intervention, researchers should report transparently the 
content of new smoking cessation websites.11
StopAdvisor is a new interactive smoking cessation 
website and, to promote transparency, details of both 
the content and development of the website have been 
published,12 and the website built with the open-source 
platform LifeGuide. The development of StopAdvisor 
was informed by addiction theory, previous research, 
and user-testing with smokers of only low 
socioeconomic status. In a pilot study, StopAdvisor 
showed promising short-term eﬀ ectiveness and 
usability,13 we therefore aimed to assess the long-term, 
biologically veriﬁ ed eﬀ ectiveness of the intervention in 
this trial.
Health inequality is a priority and to assess what eﬀ ect 
new interventions have on diﬀ erent social groups is 
important.14 Most assessments of behavioural 
interventions have not been adequately powered to 
detect eﬀ ects in low-income groups,15 and, to our 
knowledge, no previous trial of internet support for 
smoking cessation has been designed to assess the eﬀ ect 
within diﬀ erent socioeconomic status groups. This 
absence of research exists despite concerns that online 
support might be more eﬀ ective for smokers with high 
socioeconomic status on the basis of their apparent 
greater literacy to engage with support websites 
compared with smokers with low status.16 To address 
this issue, the pilot study of StopAdvisor reported 
analyses showing that the intervention was similarly 
eﬀ ective and acceptable to users across the range of 
socioeconomic status groups.13 The implication was that 
typical inequalities in online literacy might have been 
successfully mitigated by user testing done in a panel of 
smokers with low socioeconomic status during the 
development of StopAdvisor.12 However, the robustness 
of this ﬁ nding needed assessment within an adequately 
powered trial. As such, we did this study to examine the 
eﬀ ectiveness of StopAdvisor in smokers of low and high 
socioeconomic status.
Methods
Study design and participants
We did this online randomised controlled trial between 
Dec 6, 2011, and Oct 11, 2013,  in the UK. We enrolled 
participants aged 18 years and older who smoked every 
day and who were willing to make a serious quit attempt, 
use a stop-smoking website that sends email reminders, 
be followed up at 7 months, and be contacted by email and 
telephone. Participants were recruited mainly via a notice 
on the English Department of Health website called 
SmokeFree. The notice invited smokers to take part in a 
study comparing methods of online support, and included 
a link to the study website. Individuals interested in 
participating after reading the study information and 
eligibility criteria were asked for informed consent and to 
complete a baseline questionnaire. The study was 
designed with suﬃ  cient power to assess eﬀ ectiveness 
within each socioeconomic status subsample separately in 
the event of heterogeneity; as such, recruitment continued 
until the required sample size had been achieved for 
subsamples of both high and low socioeconomic status.
The study was approved by the ethics committee of 
University College London (reference 2808/001). The 
protocol17 was approved by a trial steering committee.
Randomisation and masking
Participants who completed the baseline questionnaire 
were randomly assigned (1:1) to StopAdvisor or an 
information-only control website—a one-page static 
website giving brief standard advice,12 based on a widely 
used manual for smoking cessation for practitioners.18
Randomisation was at the individual level with no 
restriction (ie, no blocking) and was completely automated 
with no experimenter involvement by use of an unseen 
random number function embedded in the website code 
to identify which treatment website was revealed after 
participants clicked the submit button at the end of the 
questionnaire. After treatment allocation, the email 
address of each participant was secured to that website to 
prevent contamination. Participants, and researchers who 
obtained data and did laboratory analyses, were masked to 
treatment allocation. We did no formal assessment of the 
extent to which masking was successful.
Procedures
All variables listed in table 1 were assessed at baseline. 
On enrolment individuals were automatically classiﬁ ed 
into one of two socioeconomic status subsamples as 
established by their responses to the baseline 
questionnaire: (1) low socioeconomic status, comprising 
individuals who have never worked, were long-term 
For more about StopAdvisor see 
http://www.lifeguideonline.org/
player/play/
stopadvisordemonstration
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unemployed, or were from routine and manual 
occupations according to the National Statistics Socio-
Economic Classiﬁ cation (NS-SEC) self-coded method,19 
and (2) high socioeconomic status, comprising 
individuals who were classiﬁ ed into all other occupational 
groups with the NS-SEC self-coded method.
Development and content of the StopAdvisor website 
have been described in detail elsewhere.12 Brieﬂ y, the 
development was informed by 19 theoretical propositions 
identiﬁ ed from the PRIME theory of motivation and 
addiction,20 33 evidence-based or theory-based behaviour 
change techniques, 26 web-design principles, and nine 
principles from user testing with smokers of low 
socioeconomic status. The theme of the website was 
based on the success of the UK’s National Health Service 
(NHS) Stop Smoking services and was aimed to simulate 
an expert stop smoking advisor who was both a source of 
useful information and a guide to help the smoker 
through the process of stopping with a structured quit 
plan. Tailored support was oﬀ ered for up to 1 month 
before and after quitting. 
The website was presented on a standard template and 
used a hybrid navigational architecture combining 
choice of content from menus with tunnelled exposure 
to key messages. Before their quit date, participants had 
access to an interactive menu, which included a 
screencast explaining how to use the website, and up to 
ﬁ ve tunnelled dialogue sessions tailored according to 
their quit date, their intended use of smoking cessation 
medicines, their success in obtaining and use of 
medicines, and reasons for quitting. These sessions 
presented behaviour-change techniques that focused on 
helping with goal setting and action planning around a 
quit date, emphasising the importance of abrupt 
cessation, acquiring appropriate medicines and how 
best to use them, making necessary changes in routines 
to minimise urges to smoke after the target quit date, 
developing speciﬁ c coping strategies for anticipated 
diﬃ  culties in quitting, and having clear expectations 
about the natures of those diﬃ  culties. In each case, 
delivery of a technique was designed to make use of the 
interactive nature of the intervention—eg, an interactive 
calendar to set quit dates and email reminders. 
After their quit date, participants had access to a new 
interactive menu and up to 13 tunnelled sessions 
tailored on self-reported abstinence, urges to smoke, 
Low SES (N=2142)* High SES (N=2471) Total (N=4613)
StopAdvisor
(n=1088)
Control
(n=1054)
StopAdvisor
(n=1233)
Control
(n=1238)
StopAdvisor
(n=2321)
Control
(n=2292)
Female 658 (61%) 632 (60%) 804 (65%) 796 (64%) 1462 (63%) 1428 (62%)
Age (years) 39·8 (14·8) 39·4 (14·3) 39·2 (11·3) 38·3 (10·9) 39·5 (13·0) 38·8 (12·5)
Married 504 (46%) 490 (47%) 643 (52%) 641 (52%) 1147 (49%) 1131 (49%)
Having children 704 (65%) 690 (66%) 678 (55%) 656 (53%) 1382 (60%) 1346 (59%)
White ethnic origin 1029 (95%) 970 (92%) 1152 (93%) 1134 (92%) 2181 (94%) 2104 (92%)
Presently in full-time education 121 (11%) 116 (11%) 71 (6%) 71 (6%) 192 (8%) 187 (8%)
No post-16 years old educational qualiﬁ cation 548 (50%) 525 (50%) 321 (26%) 293 (24%) 869 (37%) 818 (36%)
Cigarettes smoked per day 20·5 (9·4) 20·3 (9·4) 17·1 (8·1) 16·9 (8·3) 18·7 (8·9) 18·5 (9·0)
Age of smoking initiation (years)† 16·2 (5·3) 16·2 (4·3) 17·2 (4·9) 17·1 (4·2) 16·7 (5·1) 16·7 (4·2)
Never previously used support in a quit attempt 431 (40%) 434 (41%) 450 (37%) 509 (41%) 881 (38%) 943 (41%)
Never previously used behavioural support in a 
quit attempt
616 (57%) 637 (60%) 721 (59%) 798 (65%) 1337 (58%) 1435 (63%)
Made quit attempt in the previous year 394 (36%) 353 (34%) 457 (37%) 441 (36%) 851 (37%) 794 (35%)
Conﬁ dence in stopping score (1–7) 4·8 (1·7) 4·7 (1·7) 4·6 (1·6) 4·7 (1·6) 4·7 (1·7) 4·7 (1·6)
Never stopped for more than 1 week 459 (42%) 433 (41%) 348 (28%) 388 (31%) 807 (35%) 821 (36%)
Usually smokes within 5 min of waking 465 (43%) 400 (38%) 324 (26%) 298 (24%) 789 (34%) 698 (31%)
HSI score (0–6) 3·5 (1·4) 3·4 (1·4) 2·8 (1·5) 2·7 (1·5) 3·1 (1·5) 3·0 (1·5)
FTND score (0–10) 5·6 (2·3) 5·5 (2·3) 4·6 (2·5) 4·5 (2·4) 5·1 (2·4) 5·0 (2·4)
Time with smoking urges score (0–5) 3·1 (1·1) 3·0 (1·1) 2·7 (1·0) 2·7 (1·0) 2·9 (1·1) 2·9 (1·0)
Strength of smoking urges score (0–5) 3·3 (1·0) 3·2 (1·0) 3·0 (1·0) 3·0 (1·0) 3·1 (1·0) 3·1 (1·0)
MPSS-mood subscale (0–4)‡ 2·6 (0·9) 2·5 (0·9) 2·3 (0·8) 2·3 (0·8) 2·4 (0·9) 2·4 (0·9)
Time to complete online recruitment (min) 11·3 (6·8) 11·3 (6·0) 10·3 (5·9) 10·1 (6·1) 10·8 (6·4) 10·7 (6·1)
Pages viewed to complete online recruitment 19·2 (2·5) 19·1 (1·9) 19·7 (2·5) 19·5 (1·5) 19·5 (2·5) 19·3 (1·7)
Data are n (%) or mean (SD), unless otherwise indicated. *Low SES individuals were those who had never worked, were long-term unemployed, or were from routine and 
manual occupations according to the National Statistics Socio-Economic Classiﬁ cation self-coded method.19 †Data for age of smoking initiation were missing for seven 
participants (high SES: n=1 StopAdvisor, n=1 control; low SES: n=3 StopAdvisor, n=2 control). ‡The MPSS-mood subscale is the mean of responses to ﬁ ve separate states: 
depressed, irritable, restless, hungry, and poor concentration. SES=socioeconomic status. HSI=heaviness of smoking index.28 FTND=Fagerström test for nicotine 
dependence.28 MPSS=mood and physical symptoms scale. 
Table 1: Baseline characteristics 
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self-eﬃ  cacy, medicine use, and anticipated frequency of 
stressful or social events. The responses variously 
aimed to boost motivation and self-eﬃ  cacy and 
strengthen the identity of ex-smokers, and provided 
speciﬁ c advice and behaviour-change techniques about 
how to address potential diﬃ  culties and plan for the 
future to minimise their occurrence. The post-quit 
menu included frequently asked questions, a “your 
progress” section, audio and video, and a link to the 
StopAdvisor Facebook page.12
Follow-up was 7 months after enrolment to allow an 
outcome of at least 6 months abstinence; both websites 
advised quit dates within 1 month of enrolment. Follow-
up data were obtained via an online questionnaire 
emailed to participants. Non-responders were sent 
reminders using both email and telephone contact 
details (at least one and up to three telephone numbers 
[daytime, evening, and mobile]), with invitations and 
contacts structured according to evidence-based methods 
for maximisation of response rates.21 For example, all 
invitations were personalised, cited non-monetary 
incentives for responding (eg, how the answer was 
important and would inform decisions about whether to 
make the websites more widely available), and referred to 
university funding of the trial, while attempts at direct 
contact were preceded by a pre-contact, which informed 
the participant they would soon be contacted. Participants 
who reported meeting either 6 month sustained 
abstinence or point-prevalence criteria at 7-month follow-
up were asked to use a cotton dental roll to provide a 
saliva sample and post it back to a laboratory for analysis. 
To improve response rates, participants who were sent a 
kit received a £20 gift voucher, irrespective of whether or 
not they returned the sample.21
Outcomes
The primary outcome was Russell Standard 6-month 
sustained abstinence (RS6), deﬁ ned as a self-report of 
smoking no more than ﬁ ve cigarettes in the previous 
6 months and not smoking in the previous week, veriﬁ ed 
by a saliva cotinine concentration of less than 15 ng/mL22 
or, for participants reporting use of nicotine replacement 
treatment (including electronic cigarettes) and with a 
saliva cotinine concentration of more than 14 ng/ml, a 
saliva anabasine concentration of less than 1 ng/mL.23 
This deﬁ nition classiﬁ ed participants who self-reported 
Figure: Trial proﬁ le
Eight participants violated the protocol by using an alternative email address to view the other website to which they were allocated (high SES: StopAdvisor n=1, control n=4; low SES: StopAdvisor 
n=2, control n=1). Per protocol, these participants were not excluded from the analysis and classiﬁ ed by the original treatment to which they were allocated. Only one of these participants met either 
the primary or secondary outcome abstinence criteria: the participant was from the high SES subsample and was allocated to the control website and viewed StopAdvisor. SES=socioeconomic status.
7785 participants read study information 
2321 assigned to StopAdvisor
1088 low SES 
314 lost to follow-up
68 previously reported
smoking
246 assumed to have
returned to smoking 
364 lost to follow-up
51 previously reported
smoking
313 assumed to have
returned to smoking 
724 contacted at 7-month follow-up 
1088 included in primary analysis 1233 included in primary analysis 1054 included in primary analysis 1238 included in primary analysis 
919 contacted at 7-month follow-up 710 contacted at 7-month follow-up 960 contacted at 7-month follow-up 
344 lost to follow-up
69 previously reported
smoking
275 assumed to have
returned to smoking 
278 lost to follow-up
70 previously reported
smoking
208 assumed to have
returned to smoking 
1233 high SES 1238 high SES 
2292 assigned to information-only
 control website
3172 excluded
1298 declined to give consent
1419 did not complete baseline
            questionnaires
455 ineligible
361 not from the UK
75 not daily smokers
19 duplicate sign ups
1054 low SES 
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not smoking but did not meet the biochemical veriﬁ cation 
criterion as continuing smokers.
Secondary outcomes were point prevalence abstinence, 
deﬁ ned as a self-report of not smoking in the previous 
7 days at follow-up,21 veriﬁ ed by saliva cotinine or 
anabasine; and quantitative indices of website interaction 
(logins, page views, and time spent on website).We also 
assessed self-reported abstinence at months 2 and 4 after 
enrolment, self-report of a serious quit attempt at the 
7-month follow-up, and satisfaction ratings of the website 
at months 2 and 7 after enrolment. Due to low response 
rates for these outcomes they were omitted from the 
main analyses before unblinding the data (appendix).
Statistical analysis
The sample size was established with α and β (1-power) 
set at 5% for a projected 3% intervention diﬀ erence (ie, 
8% vs 5%) in the whole sample, whilst ensuring at least 
80% power to detect this diﬀ erence in either 
socioeconomic status subsample in the event of 
heterogeneity. Although the anticipated eﬀ ect size is 
smaller than usually observed with face-to-face 
behavioural support, it is clinically meaningful and 
potentially cost eﬀ ective.24 Hence, a minimum total 
sample size of 4260 with at least 2130 in each subsample 
was required.
We used log-binomial regression to analyse the 
dichotomous primary and secondary outcomes, and 
calculated the associated relative risk and 95% CIs. The 
model allowed both the initial assessment of 
homogeneity of eﬀ ect across subsamples by inclusion 
of an intervention by socioeconomic status interaction 
term and adjustment in sensitivity analyses for any 
chance imbalances in baseline characteristics between 
intervention groups. The interaction term provided an 
assessment of the homogeneity of eﬀ ect because it 
represented the ratio of the risk ratios (RRs) for the 
intervention eﬀ ect in the subsample of participants 
with low socioeconomic status and the intervention 
eﬀ ect in those with high status. So far as the true 
intervention eﬀ ect was the same in both subsamples, 
the RRs would be identical (except for sampling error) 
and their ratio would be about 1—ie, no interaction. 
Alternatively, an interaction in the initial analysis 
would show heterogeneous intervention eﬀ ects across 
socioeconomic status subsamples, which should 
therefore be assessed separately within each 
subsample. We anticipated the possibility of 
heterogeneity and thus speciﬁ ed the threshold for 
absence of homogeneity of eﬀ ect at a p value of less 
than 0·10.25,26 The protocol speciﬁ ed logistic regression 
and associated odds ratios (ORs) as the measure of 
eﬀ ect, but we used relative risk to improve 
understanding. To provide per-protocol analyses, we 
also calculated ORs, percentage-point diﬀ erences, and 
95% CIs. On the basis of the intention-to-treat 
principle, individuals who did not respond to endpoint 
follow-up attempts were retained in the analyses and 
classiﬁ ed as continuing smokers according to the 
RS6 criteria.22 As post-hoc sensitivity analyses, we re-
examined the models: with exclusion of participants in 
full-time education from the classiﬁ cation of those in 
the subsample with low socioeconomic status to assess 
the eﬀ ect on results of individuals who might have 
been inappropriately classiﬁ ed; with reclassiﬁ cation of 
individuals with low socioeconomic status as those 
who did not have post-16 education to assess whether 
results extended across an alternative operationalisation 
of socio economic status; and with self-reported 
smoking cessation at the 7 month endpoint to show the 
eﬀ ect of biochemical veriﬁ cation. We compared 
website usage with t tests without the assumption of 
equality of variance. We did analyses with SPSS 
(version 22.0.0.0).
The study is registered as an International Standard 
Randomised Controlled Trial, number ISRCTN99820519.
Role of funding source
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. JB, JAS, and RW had full access to 
all the data in the study and JB had ﬁnal responsibility for 
the decision to submit for publication.
Results
The ﬁ gure shows the trial proﬁ le.27 We randomly assigned 
4613 participants to the StopAdvisor group (n=2321) or 
the control group (n=2292); 2142 participants were of low 
socioeconomic status and 2471 participants were of high 
status (ﬁ gure 1). 1300 (28%) participants were lost to 
follow-up (ﬁ gure 1). However, of these, 258 (20%) 
individuals reported usual smoking at a time in the 
6 months before the ﬁ nal follow-up, which would have 
classiﬁ ed them as smokers by our sustained abstinence 
(RS6) primary outcome, meaning that the eﬀ ective 
follow-up rate for the primary outcome was 77% 
(1300 − 258=1042, 4613 − 1042=3571, 3571/4613). This rate 
was not dissimilar between intervention groups, or 
between intervention groups within the diﬀ erent 
socioeconomic subsamples (ﬁ gure 1). The remaining 
1042 (23%) participants were assumed to have continued 
smoking according to RS6 criteria. Baseline characteristics 
of participants assumed to be smoking did not diﬀ er 
between intervention groups, or between intervention 
groups within the diﬀ erent socioeconomic status 
subsamples (data not shown).
In the recruited sample, daily cigarettes smoked and 
measures of tobacco dependence were high28 and a third 
of participants had not stopped for more than 1 week 
since becoming a regular smoker (table 1). About 60% of 
participants had never previously used any behavioural 
support during a quit attempt, while about 40% had 
never previously used any type of smoking cessation 
treatment (table 1). Baseline characteristics were similar 
See Online for appendix
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in the two intervention groups overall and within the 
diﬀ erent socioeconomic subsamples (table 1). Both 
intervention groups, irrespective of socioeconomic 
status, showed a similar level of engagement with the 
trial recruitment website, spending roughly 11 min to 
view and interact with a mean of 19 pages (table 1).
The overall rate of smoking cessation was similar 
between participants in the StopAdvisor and control 
groups for both the primary (237 [10%] vs 220 [10%] 
participants; relative risk [RR] 1·06, 95% CI 0·89–1·27; 
p=0·49) and the secondary (358 [15%] vs 332 [15%] 
participants; 1·06, 0·93–1·22; p=0·37) outcomes. However, 
analysis of the interaction between intervention and 
socioeconomic status showed clear evidence of non-
ignorable heterogeneity of intervention eﬀ ect by both 
primary (RR 1·44, 95% CI 0·99–2·09; p=0·0562) and 
secondary (1·37, 1·02–1·84; p=0·0360) cessation measures. 
This ﬁ nding was evident before and after adjustment for 
all other baseline characteristics (adjusted data not shown). 
Consequently, the analysis of outcome was done separately 
within each of the two socioeconomic status subsamples.
In the subsample of participants with low 
socioeconomic status, a beneﬁ t of StopAdvisor was 
evident for both primary and secondary measures 
compared with the information-only website, whereas in 
those with high socioeconomic status, no evidence of a 
diﬀ erence was shown (table 2). Adjustment for all 
baseline characteristics had a negligible eﬀ ect on these 
comparisons (table 2). In a post-hoc sensitivity analysis, 
we re-examined the eﬀ ect of StopAdvisor on 
biochemically veriﬁ ed smoking cessation in participants 
with low socioeconomic status, after exclusion of those in 
full-time education from the classiﬁ cation (n=237). The 
beneﬁ t of StopAdvisor compared with the information-
only website remained in both unadjusted (primary 
outcome 87 [9%] of 967 vs 60 [6%] of 938 participants; 
RR 1·41, 95% CI 1·03–1·93; p=0·0346; secondary 
outcome 130 [13%] vs 88 [9%] participants; 1·43, 
1·11–1·85; p=0·0057) and adjusted (primary outcome 
1·48, 1·07–2·04; p=0·0170; secondary outcome 1·52, 
1·18–1·97; p=0·0013) models. In a second sensitivity 
analysis, we re-examined the models with low 
socioeconomic status participants reclassiﬁ ed as those 
who did not have post-16 education. In this smaller 
subsample (n=1687), the results were consistent with the 
primary analyses for StopAdvisor versus information 
only, but were non-signiﬁ cant in both the unadjusted 
(primary outcome 80 [9%] of 869 vs 60 [7%] of 
818 participants; RR 1·26, 95% CI 0·91–1·73; p=0·17; 
secondary outcome 111 [13%] vs 86 [11%] participants; 
1·21, 0·93–1·58; p=0·15) and adjusted (primary outcome 
1·27, 0·92–1·75; p=0·15; secondary outcome 1·21, 
0·92–1·58; p=0·17) models. In a ﬁ nal post-hoc sensitivity 
analysis, we re-examined the eﬀ ect of StopAdvisor with 
self-reported rather than biochemically veriﬁ ed measures 
of smoking cessation at the 7 month endpoint. On the 
basis of similar rates of failing the biochemical 
veriﬁ cation criteria between intervention groups, the 
new analyses showed a similar pattern of results as those 
reported in table 2 (appendix). In the subsample with low 
socioeconomic status, StopAdvisor showed beneﬁ t 
compared with information only; however, results were 
not signiﬁ cant (self-reported 6 month abstinence 
141 [13%] of 1088 vs 114 [11%] of 1054 participants, 
unadjusted RR 1·20, 95% CI 0·95–1·51; p=0·13; adjusted 
RR 1·23, 0·97–1·56; p=0·08; self-reported point-
prevalence 227 [21%] vs 195 [19%] participants, unadjusted 
RR 1·13, 0·95–1·34; p=0·17; adjusted RR 1·18, 0·99–1·40; 
p=0·07). That statistical tests of self-reported measures 
in participants with low socioeconomic status subsample 
failed to reach signiﬁ cance was probably related to the 
decreased power to detect a percentage diﬀ erence 
between the two groups because of the increased absolute 
rates.
StopAdvisor Control Relative risk (95% CI) Odds ratio (95% CI)* Percentage-point 
diﬀ erence (95% CI)
p value†
Primary outcome (abstinence for 6 months)
High SES 147/1233 (12%) 156/1238 (13%) 0·95 (0·77 to 1·17) 0·94 (0·74 to 1·19) –0·68 (–3·27 to 1·91) 0·61
Adjusted .. .. 0·97 (0·78 to 1·19)‡ 0·95 (0·75 to 1·22)‡ .. 0·75
Low SES 90/1088 (8%) 64/1054 (6%) 1·36 (1·00 to 1·86) 1·39 (1·00 to 1·94) 2·20 (0·02 to 4·38) 0·0499
Adjusted .. .. 1·43 (1·05 to 1·96)‡ 1·46 (1·04 to 2·05)‡ .. 0·0238
Secondary outcome (point prevalence at 6 months)
High SES 222/1233 (18%) 232/1238 (19%) 0·96 (0·81 to 1·13) 0·95 (0·78 to 1·17) –0·74 (–3·79 to 2·32) 0·64
Adjusted .. .. 0·96 (0·82 to 1·14)‡ 0·95 (0·77 to 1·17)‡ .. 0·66
Low SES 136/1088 (13%) 100/1054 (10%) 1·32 (1·03 to 1·68) 1·36 (1·04 to 1·79) 3·01 (0·37 to 5·66) 0·0267
Adjusted .. .. 1·39 (1·09 to 1·78)‡ 1·41 (1·07 to 1·88)‡ .. 0·0081
Data are n/N (%), unless otherwise indicated. SES=socioeconomic status. The rate for reporting not smoking but failing to provide biochemical veriﬁ cation was 5% 
(207/4613) for the primary outcome and 9% (392/4613) for the secondary outcome; these rates were similar between the intervention groups in each SES subsample. 
Participants lost to follow-up were counted as treatment failures. *Odds ratios rather than relative risks were speciﬁ ed as the measure of eﬀ ect in the protocol. Relative risks 
were also calculated to improve understanding. †In the case of the adjusted analyses, p values relate to the log-binomial models used to calculate the relative risk. ‡The 
primary analyses were all unadjusted. Adjusted results are presented as a sensitivity analysis. The adjusted models include all characteristics presented in table 1. 
Table 2: Eﬀ ect of StopAdvisor on biochemically veriﬁ ed smoking cessation 
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StopAdvisor was used more regularly than the control 
website in terms of log-ins, page views, and time spent 
on the website (table 3). This eﬀ ect was evident in both 
socioeconomic status subsamples, but was slightly larger 
in participants with high socioeconomic status. In the 
StopAdvisor group, 1216 participants (52%; low 
socioeconomic status 535 [49%] of 1088 participants; 
high socioeconomic status 681 [55%] of 1233 participants) 
chose to use the interactive calendar to set a quit date and 
741 (32%; low socioeconomic status 327 [30%]; high 
socioeconomic status 414 [34%]) opted to report use of a 
stop smoking drug and receive ongoing advice tailored to 
the drug type. In both socioeconomic status subsamples, 
in participants accessing the pre-quit interactive menu, 
the item most often selected at least once during the ﬁ rst 
visit was a section entitled “what is the secret to success?”, 
which aimed to boost motivation and self-eﬃ  cacy, 
strengthen ex-smoker identity, and oﬀ er advice about 
stop-smoking drugs (low socioeconomic status 302 [28%] 
of 1069 participants; high socioeconomic status 436 [36%] 
of 1223 participants). This item remained the most 
popular in participants who revisited the menu before 
their quit date (low socioeconomic status 105 [33%] of 
319 participants; high socioeconomic status 133 [37%] of 
359 participants). During the ﬁ rst post-quit date dialogue 
session, of participants who reported cravings and 
received a self-regulatory control tip, most requested at 
least one additional tip (low socioeconomic status 
108 [53%] of 204 participants; high socioeconomic status 
181 [65%] of 280 participants). Of participants visiting the 
post-quit interactive menu, the items most often selected 
at least once during the ﬁ rst visit by smokers of low 
socioeconomic status (n=260) were the “your progress” 
section, which tracked days since quitting, money saved, 
and health beneﬁ ts accrued (n=68 [26%]); audio of 
relaxation techniques (n=54 [21%]); and sections 
featuring a gallery of motivational pictures and music to 
improve mood and distract (n=both 52 [20%]), whereas 
smokers with high socioeconomic status (n=378) selected 
sections monitoring ‘your progress’ (140 [37%]), why 
cigarettes are addictive (94 [25%]), and frequently asked 
questions (91 [24%]). During re-visits to this menu, the 
“your progress” section remained the most often selected 
at least once in both subsamples (low socioeconomic 
status 142 [67%] of 215; high socioeconomic status 
219 [68%] of 320).
Assessment of outcomes omitted from the main 
analyses on the basis of low response rates (ranging from 
972 [21%] of 4613 to 2211 [48%] of 4613 participants) was 
consistent with analyses of the primary and secondary 
outcomes (appendix). Self-reported abstinence at 
2 months and 4 months after enrolment was numerically, 
but not signiﬁ cantly, greater in participants allocated to 
StopAdvisor than in those allocated to the control website 
in the subsample with low socioeconomic status, whereas 
the rates were almost identical in those with high 
socioeconomic status (appendix). Self-report of a serious 
quit attempt was similar between groups in both 
socioeconomic status subsamples, and the satisfaction 
ratings were consistently higher for StopAdvisor than for 
the control website (appendix).
Discussion
Our ﬁ ndings show that overall rates of cessation were 
similar between participants allocated to the interactive 
StopAdvisor website and those in the brief-advice control 
group, but the intervention eﬀ ect was dependent on 
socioeconomic status—StopAdvisor was an eﬀ ective aid 
to smoking cessation in smokers of low, but not high, 
socioeconomic status. Furthermore, StopAdvisor 
resulted in greater usage than did the static, brief-advice 
website.
Health inequality is a global research priority. A 
strength of this study is that, to our knowledge, it is the 
ﬁ rst to focus on the eﬀ ect of internet support on smoking 
within diﬀ erent socioeconomic status groups (panel). 
The ﬁ nding that StopAdvisor helped smokers in low but 
not high socioeconomic status groups suggests that 
concern about online support being more eﬀ ective for 
smokers in high socioeconomic groups is unwarranted.16 
Findings from previous studies have shown that 
smokers of low socioeconomic status engaged less with 
internet-based support,16 which may have arisen from 
inequalities in online literacy. However, the user testing 
of StopAdvisor was done exclusively in smokers with low 
socioeconomic status and seems to have been successful 
in producing an eﬀ ective website for that group.12 This 
outcome could have been at the expense of failing to 
meet the needs of smokers with high socioeconomic 
status. Future research should explore this possibility 
with a view to tailor the content of StopAdvisor to 
socioeconomic status. In the meantime, StopAdvisor 
StopAdvisor 
(n=2321)
Control 
(n=2292)
t test* Mean diﬀ erence 
(95% CI)
p value
Log-ins†
High SES 5·0 (6·2) 1·4 (0·7) t(1267) 20·1 3·6 (3·2–3·9) <0·0001
Low SES 4·1 (5·7) 1·3 (0·6) t(1113) 16·4 2·9 (2·5–3·2) <0·0001
Total time (min)‡
High SES 26·9 (38·9) 1·3 (3·2) t(1248) 23·1 25·6 (23·5–27·8) <0·0001
Low SES 22·1 (34·4) 1·1 (2·5) t(1099) 20·1 21·1 (19·0–23·1) <0·0001
Total page views
High SES 93·1 (119·8) 6·1 (5·2) t(1237) 25·5 87·0 (80·3–93·7) <0·0001
Low SES 75·5 (105·0) 5·3 (4·1) t(1090) 22·0 70·2 (64·0–76·5) <0·0001
Data are mean (SD), unless otherwise indicated. All analyses in this table are unadjusted. SES=socioeconomic status. 
*Data in parentheses  are degrees of freedom. †The modal number of log-ins was 1 for both treatments in each SES 
subsample. The appendix provides log-in data presented categorically. ‡Time on website is an underestimate–time on 
last page is always unknown in LifeGuide interventions. Interaction between a browser and LifeGuide server happens 
when a page is loaded. After that, there is no further communication until another page is loaded from the same 
server. Time on page is calculated by taking the exact time a page was loaded (from the Lifeguide server) and 
comparing it with the exact time that the previous page in the session was loaded. When a user closes their tab, or just 
types a diﬀ erent website in to the address bar, no interaction happens between the browser and the server, so it is not 
possible to identify the time the ﬁ nal action occurred.
Table 3: Usage of StopAdvisor versus the control website
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could be implemented easily and made freely available; 
smokers with high socioeconomic status would be 
unlikely to beneﬁ t, but no evidence shows that use of the 
website would lead this group to be any less successful 
at quitting.
Although the eﬀ ect on cessation in smokers with low 
socioeconomic status was relatively modest (RR 1·4), this 
ﬁ nding is clinically signiﬁ cant because of the huge health 
gains associated with stopping smoking. An eﬀ ect of as 
little as 1% on rates of 6-month sustained abstinence 
would result in at least 3 additional years of life for every 
100 40-year-old smokers treated.24 Additionally, the eﬀ ect 
size is not dissimilar to other modes of delivery for 
behavioural support (meta-analyses of cessation after at 
least 6 months compared with nothing or minimal 
controls: telephone counselling RR 1·3 [44 studies based 
on 1557 successes from 12 388 vs 1201 of 
12 423 participants]; individual counselling RR 1·4 
[22 studies based on 564 of 4665 vs 433 of 4922 
participants]; mobile-phone-based intervention RR 1·7 
[ﬁ ve studies based on 444 of 4730 vs 240 of 4370 
participants]),5 and internet-based interventions may be 
more cost-eﬀ ective than other interventions because of 
the potential reach and relatively small ongoing costs.
The absolute rates of cessation were high in our study: 
8% in the intervention group and 6% in the control group 
in smokers of low socioeconomic status, and 12% 
averaged across both groups in those of high 
socioeconomic status. By comparison, the rate was 6% 
across treatment groups in the only other trial of internet 
support to have reported biochemically veriﬁ ed measures 
of sustained abstinence,30 and a frequently cited 
assessment of text-messaging support for cessation 
reported rates of 11% in the intervention group and 5% in 
the control group.19 The relatively high rates in participants 
allocated to the control website in the present study draws 
attention to the pragmatic nature of the trial, which tested 
the eﬀ ect of StopAdvisor over and above all other available 
real-world treatments, including support oﬀ ered on the 
site through which participants were recruited to the trial. 
The increased rates in smokers with high socioeconomic 
status compared with those of low status shows the well 
established gradient in success rates between the groups.8 
Although the quit rates were reduced in participants 
allocated to StopAdvisor in smokers of low socioeconomic 
status compared with those of high status, the salient 
point is that the gradient seems reduced relative to those 
allocated to the control website in smokers of low 
socioeconomic status.
The intervention engaged a large proportion (roughly 
60%) of smokers who had never previously used 
behavioural support. This ﬁ nding should mitigate 
concern about internet support mainly engaging 
smokers who would otherwise have used treatments 
with an established evidence base, such as face-to-face 
behavioural support. There is a law of attrition in 
electronic health care, which speciﬁ es a substantial 
proportion of users drop out before completion of 
treatment.31 The mean usage of StopAdvisor was between 
four and ﬁ ve log-ins, which compares favourably with 
other relevant trials,32 but masks variability in users, 
whereby a substantial proportion of participants will only 
have used StopAdvisor once. Future research should 
examine how prompts and reminders can best engage an 
increased proportion of users to maintain interaction 
with treatment websites.
Our study has limitations. First, we recruited parti-
cipants directly from the internet. As such, this study 
has shown that the intervention is eﬀ ective for the kinds 
of smokers of low socioeconomic status who have access 
to the internet. In the future, whether the intervention 
will be able to reduce health inequalities resulting from 
Panel: Research in context
Systematic review
We consulted a recent Cochrane review and did a meta-analysis of the eﬀ ectiveness of 
interactive internet-based smoking cessation interventions.10,29 The meta-analysis was 
done at the start of the project and included studies obtained from searches of 
computerised databases done in December, 2008: PubMed (1990–2008/12), PsycINFO 
(1990–2008/12), CINHAL Plus (1990–2008), EconLit (1990–2008/11), ISI Web of Science 
(SCI, SSCI, AHCI; 1990–2008), and CENTRAL (Cochrane Registry of Controlled Trials, 
1990–2008).29 We searched Medline with relevant MeSH terms {[(“Online Systems” OR 
“Internet”) AND “Smoking Cessation”] AND “Randomized Controlled Trial”}. All other 
databases were searched with free text terms: {[(“Internet” OR “Online” OR “Web”) AND 
“Smoking cessation”] AND (“RCT” OR “Randomi$ed controlled trial” OR “Random* 
trial”)]}. We included 11 relevant randomised controlled trials and found a signiﬁ cant 
treatment eﬀ ect (RR 1·5), but that there was also signiﬁ cant heterogeneity in eﬀ ect size. 
The Cochrane review was done in April, 2013, and searched the Cochrane Tobacco 
Addiction Group register for records including the terms “internet” or “www*” or “web” 
or “net” or “online”. The specialised register included results from CENTRAL, MEDLINE, 
EMBASE, and PsycINFO. The review identiﬁ ed 28 relevant studies but clinical and 
statistical heterogeneity limited the ability to pool studies.10 Although there is a huge 
potential for these interventions to have a high impact at low-cost, our conclusion is 
that existing research has produced mixed results and is limited by a scarcity of 
biochemically veriﬁ ed long-term outcomes.10 The present trial addressed this limitation  
by assessing 6 month sustained, biochemically veriﬁ ed abstinence. Internet-based 
smoking cessation interventions might be less eﬀ ective for smokers with low 
socioeconomic status than for those with high status because of their apparent lower 
online literacy to engage with support websites.16 The present trial was, to our 
knowledge, the ﬁ rst to evaluate a website designed with particular attention  to smokers 
with low socioeconomic status and to focus on the eﬀ ect of internet support on smoking 
within diﬀ erent socioeconomic status groups.
Interpretation
Our ﬁ ndings show that the interactive internet-based smoking cessation intervention, 
StopAdvisor, is more eﬀ ective than an information-only website in smokers with low, but 
not high, socioeconomic status. User testing of the website was done exclusively in 
smokers with low socioeconomic status and seems to have been successful in producing 
an eﬀ ective website for that group.12 Future research should explore whether this 
outcome was at the expense of meeting the needs of smokers with high socioeconomic 
status. In the meantime, StopAdvisor could be implemented easily and made freely 
available; smokers with high socioeconomic status would be unlikely to beneﬁ t, but there 
is no evidence that their use of the website would lead them to be any less successful.
Articles
www.thelancet.com/respiratory   Vol 2   December 2014 1005
smoking will also be dependent on uptake. The issue is 
not straightforward, because on one hand, smokers with 
low socioeconomic status tend to have less access to the 
internet than do those with high status,33 but on the 
other hand, they are just as likely to express interest in 
use of online support,9 and the diﬀ usion of internet 
access has been rapid and will only increase.34 Second, 
the research was done in a high-income country. Our 
ﬁ ndings will not necessarily generalise to other countries 
where low socioeconomic status groups might have less 
online experience and skills than do those in the UK. 
Although cost-eﬀ ective population approaches to 
cessation, including internet-based support, are 
particularly appealing to individuals in low-income and 
middle-income countries, further assessment is needed 
within those contexts before the approach can be 
recommended conﬁ dently. Third, we were unable to 
comprehensively assess participants’ use of other 
treatments during the trial. The eﬀ ective use of other 
treatments—particularly stop-smoking drugs—might 
have been a key moderator of eﬀ ectiveness. StopAdvisor 
is a complex intervention that has been developed on the 
basis of evidence, theory, user and web-design input, 
and with the primary intention that the website should 
be maximally eﬀ ective. The ﬁ nding that the diﬀ erence in 
log-ins, time on webpages, and page views between the 
control and intervention websites was similar between 
socioeconomic status subsamples suggests that this type 
of usage did not mediate the eﬀ ectiveness of StopAdvisor 
for smokers of low socioeconomic status. Future 
research should identify the causal components, possibly 
in a series of fractionated factorial designs that could 
allow StopAdvisor to be reﬁ ned and optimised.35,36 That 
the trial has been done with detailed and transparent 
reporting of the development and content of the website 
should aid this process.12 In the meantime, the trial has 
pragmatically shown that StopAdvisor is more eﬀ ective 
than the types of websites that are typically used by 
smokers with low socioeconomic status searching for 
online support in the UK—ie, static information-only 
websites. Fourth, socio economic status is a complex 
concept and diﬃ  cult to assess without an interviewer 
being present. Use of the NS-SEC measure beneﬁ tted 
from being validated, but use of an occupationally-based 
assessment of socioeconomic status was limited by the 
classiﬁ cation of never workers into the low socio-
economic status group in the dichotomised version. 
This limitation likely accounted for the greater 
proportion of participants with low socioeconomic status 
being in full-time education than those with high 
socioeconomic status. However, the NS-SEC measure 
did seem to accurately report the eﬀ ect of socioeconomic 
status in other respects: compared with smokers with 
high socioeconomic status, those with low socioeconomic 
status were less likely to have post-16 qualiﬁ cations or be 
married, and were more likely to be heavier and more 
dependent smokers who started smoking at a younger 
age. Consistent with this limitation, the beneﬁ t of 
StopAdvisor over the information-only control website 
seemed to be slightly greater in the post-hoc sensitivity 
analysis, which excluded smokers in full-time education 
from the subsample with low socio economic status. 
StopAdvisor could be implemented easily and made 
freely available by health organisations, which would 
probably improve the success rates of smokers with low 
socioeconomic status who are seeking online support. 
Clinicians should continue recommending smokers to 
use face-to-face support combined with stop-smoking 
medicines, but when this is not possible they could 
consider recommending online support.
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